⚲
|
Exome Asset Management LLC
✚
| |
---|---|
CRD # | 304585 |
SEC # | 801-121896 |
CIK # | 0002011932 |
AUM | $181.8 MM (2024-03-28) |
Employees | 9 (56% Investors, 0% Brokers) |
Phone | 212-403-3900 |
Address | 330 Madison Avenue New York, NY 10017 |
Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
Total AUM ($MM) |
---|
CIK | Period |
---|---|
0002011932 | |
/ |
Sector | Form 13F Holdings | Cap ($MM) | Value ($MM) |
---|---|---|---|
Lilly Eli & Co | 301,789.7 | 8.8 | |
Avi Biopharma Inc | 6,533.7 | 5.2 | |
BeiGene Ltd | 17,043.8 | 4.7 | |
Manhattan Pharmaceuticals Inc | 586.4 | 4.5 | |
Cigna Corp | 84,461.4 | 4.0 | |
Corbus Pharmaceuticals Holdings Inc | 33.8 | 3.8 | |
Insmed Inc | 2,379.6 | 3.8 | |
Amgen Inc | 130,083.0 | 3.7 | |
Desert Gateway Inc | 1,504.7 | 3.6 | |
Synta Pharmaceuticals Corp | 1,228.5 | 3.0 | |
Dexcom Inc | 29,320.0 | 2.9 | |
Autolus Therapeutics PLC | 258.2 | 2.9 | |
Intuitive Surgical Inc | 72,505.6 | 2.8 | |
Dr Reddys Laboratories Ltd | 9,175.8 | 2.8 | |
FS Development Corp | 2.7 | ||
Ascendis Pharma A/S | 5,198.1 | 2.7 | |
Zeta Acquisition Corp III | 1,163.5 | 2.7 | |
Merus NV | 941.6 | 2.7 | |
Masimo Corp | 7,608.0 | 2.5 | |
Centessa Pharmaceuticals PLC | 433.5 | 2.5 | |
Wave Life Sciences Ltd | 220.3 | 2.4 | |
Guardant Health Inc | 4,307.3 | 2.3 | |
Cabaletta Bio Inc | 30.1 | 2.2 | |
Arvinas Inc | 2,269.1 | 2.2 | |
Natera Inc | 3,633.0 | 2.0 | |
Biohaven Ltd | 10,260.1 | 2.0 | |
Bridgebio Pharma Inc | 1,284.9 | 2.0 | |
Fulcrum Therapeutics Inc | 198.1 | 1.9 | |
Apellis Pharmaceuticals Inc | 4,727.4 | 1.8 | |
Prev | Page 1 | Next |
Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
---|---|---|---|---|
HF | Emerging Markets Healthcare Partners LLC | [2019-08-28] | 0.0 | 78.8 |
HF | Worldwide Healthcare Partners LLC | [2019-08-28] | 0.0 | 87.0 |
AUM Breakdown | Accounts | AUM ($MM) |
---|---|---|
By Client Type | ||
(a) Individuals (other than high net worth individuals) | 0 | 0.0 |
(b) Individuals (high net worth individuals) | 0 | 0.0 |
(c) Banking or thrift institutions | 0 | 0.0 |
(d) Investment companies | 0 | 0.0 |
(e) Business development companies | 0 | 0.0 |
(f) Pooled investment vehicles | 5 | 181.8 |
(g) Pension and profit sharing plans | 0 | 0.0 |
(h) Charitable organizations | 0 | 0.0 |
(i) State or municipal government entities | 0 | 0.0 |
(j) Other investment advisers | 0 | 0.0 |
(k) Insurance companies | 0 | 0.0 |
(l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
(m) Corporations or other businesses not listed above | 0 | 0.0 |
(n) Other | 0 | 0.0 |
Total | 5 | 181.8 |
By Discretionary | ||
Discretionary | 5 | 181.8 |
Non-Discretionary | 0 | 0.0 |
Total | 5 | 181.8 |
By Non-United States Persons | ||
Non-United States Persons | 3.2 | |
United States Persons | 178.7 | |
Total | 5 | 181.8 |
Form D Directors | # Filings | # Firms | 2011 - 2024 |
---|---|---|---|
Samuel Isaly | 21 |
EDGAR Form | CIK | 2011 - 2024 |
---|---|---|
13F-HR | [0002011932] |
Comparable Firms | State | AUM ($BB) |
---|---|---|
RVX Asset Management LLC
✚
|
FL | 0.2 |
Prime Meridian Capital Management LLC
✚
|
CA | 0.2 |
The Visualize Group LP
✚
|
NY | 0.2 |
Norwood Investment Partners LP
✚
|
CA | 0.2 |
Twenty ACRE Capital LP
✚
|
PA | 0.2 |
Octagon Asset Management LLC
✚
|
NC | 0.2 |
OM Advisers LP
✚
|
NJ | 0.2 |
Vision One Management Partners LP
✚
|
FL | 0.2 |
Seven Canyons Advisors LLC
✚
|
UT | 0.2 |
Forsyth Street Asset Management LLC
✚
|
NY | 0.2 |